“Research is to see what everybody else has seen, and to think what nobody else has thought.
“Research is to see what everybody else has seen, and to think what nobody else has thought.
— Albert Szent-Györgyi
Embedded Files
I am Deepa Dehari, a researcher in Pharmaceutical Engineering and Technology with a Ph.D. from IIT (BHU) Varanasi. My work focuses on innovative solutions for antimicrobial resistance, especially through bacteriophage therapy and advanced drug-delivery systems.
I am currently a Postdoctoral Scholar at the University of California, Davis (Department of Dermatology) in Shafikhani Lab, where I work on acute-phase wound infection minimization, immunomodulator-based infection therapy, and burn wound healing models in collaboration with Prof. Athena Shoulika.
My expertise spans bacteriophage formulations, nanotechnology-driven drug delivery, wound-healing therapeutics, and translational dermatology research. I have contributed to several high-impact publications, international conference presentations, and have experience in teaching, industrial research, and advanced laboratory methodologies.
Driven by a commitment to innovative healthcare, my goal is to develop transformative pharmaceutical technologies that improve infection management and wound healing outcomes.
Nice to Meet You
Nice to Meet You
I am originally from Chhattisgarh and completed my M.Pharm. and Ph.D. in Pharmaceutics at IIT (BHU) Varanasi. After a year of industrial experience at Apotex Research Pvt. Ltd. in Analytical R&D, I returned to IIT (BHU) for my doctoral research in advanced drug delivery and antimicrobial therapeutics.
I am currently a Postdoctoral Scholar at the University of California, Davis, Department of Dermatology, where I work on acute wound infection control, immunomodulator-based therapies, and burn wound healing models. My expertise spans formulation science, microbiology, molecular biology, and preclinical wound models.
I am skilled in techniques such as ELISA, Western blotting, in vitro cell culture, immune cell isolation, microbial culture and infection assays, as well as analytical tools including HPLC, UV–Vis, FTIR, ATR, zetasizer, confocal microscopy, RT-PCR, and advanced wound-healing methodologies. I am also proficient in GraphPad Prism, DOE, Chemdraw, ZEISS ZEN, and scientific literature tools.
Dedicated and detail-oriented, I combine strong experimental skills with a consistent, problem-solving approach to deliver high-quality research in pharmaceutics, infection biology, and translational dermatology.
Research Highlights
Bacteriophage entrapped chitosan microgel for the treatment of biofilm-mediated polybacterial infection in burn wounds, IJBM, 2023.
Luliconazole Nail Lacquer for the Treatment of Onychomycosi, AAPSPharmSciTech, 2022.
Enhanced Therapeutic Efficacy Against Melanoma through Exosomal Delivery of Hesperidin, ACS Molecular Pharmaceutics, 2024
Anacardic acid encapsulated solid lipid nanoparticles for Staphylococcus aureus biofilm therapy, Drug Delivery and Translational Research, 2020
Page updated
Google Sites
Report abuse